Last reviewed · How we verify
Esketamine of single injection — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Esketamine of single injection (Esketamine of single injection) — Yangzhou University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Esketamine of single injection TARGET | Esketamine of single injection | Yangzhou University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Esketamine of single injection CI watch — RSS
- Esketamine of single injection CI watch — Atom
- Esketamine of single injection CI watch — JSON
- Esketamine of single injection alone — RSS
Cite this brief
Drug Landscape (2026). Esketamine of single injection — Competitive Intelligence Brief. https://druglandscape.com/ci/esketamine-of-single-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab